Skip to main content
Top
Published in: Supportive Care in Cancer 9/2007

Open Access 01-09-2007 | Original Article

Personality and fatigue in patients with benign or malignant breast disease

Authors: Helen J. Michielsen, Alida F. W. Van der Steeg, Jan A. Roukema, Jolanda De Vries

Published in: Supportive Care in Cancer | Issue 9/2007

Login to get access

Abstract

Goals of work

The aim of the study was to examine the role of five general personality traits in fatigue in a group of patients with breast cancer (BC) and a group with benign breast problems (BBP).

Materials and methods

Of the 304 participating women, 127 patients had BC and 177 BBP. A fatigue scale was completed before diagnosis and 1, 3, and 6 months after diagnosis (benign patients) or surgical treatment (BC patients). A personality questionnaire (NEO-FFI) and a depression scale (CES-D) were completed before diagnosis.

Main results

The BC group was less tired before diagnosis, more tired 1 month after diagnosis, and equally tired 3 and 6 months after diagnosis. In the total group, women were more tired over time when they were more neurotic, less agreeable, or more introverted. After controlling for depressive symptoms, demographics, and medical factors, baseline depressive symptoms (β = 0.29, p < 0.05), neuroticism (β = 0.29, p < 0.05), and extraversion (β = −0.25, p < 0.05) predicted fatigue 6 months later. After also including baseline fatigue, only neuroticism (β = 0.22, p < 0.05) and baseline fatigue (β = 0.79, p < 0.001) predicted fatigue.

Conclusions

Personality is more strongly related to fatigue than demographics, the diagnosis cancer, receiving cancer treatment, and baseline depressive symptoms and fatigue. When replicated, screening and treating women who are at risk to experience high levels of fatigue is recommended.
Literature
1.
go back to reference Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRef Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRef
2.
go back to reference Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21:1–18PubMedCrossRef Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21:1–18PubMedCrossRef
3.
go back to reference Association of Comprehensive Cancer Centres (1998) Incidence of cancer in The Netherlands. Drukkerij De Kempen, Utrecht, The Netherlands Association of Comprehensive Cancer Centres (1998) Incidence of cancer in The Netherlands. Drukkerij De Kempen, Utrecht, The Netherlands
4.
go back to reference Beekman ATF, Deeg DJH, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W (1997) Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 27:231–235PubMedCrossRef Beekman ATF, Deeg DJH, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W (1997) Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 27:231–235PubMedCrossRef
5.
go back to reference Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604–611PubMed Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604–611PubMed
6.
7.
go back to reference Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538PubMedCrossRef Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538PubMedCrossRef
8.
go back to reference Cohen JW (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, NJ Cohen JW (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, NJ
9.
go back to reference Costa PT Jr, McCrae RR (1989) NEO PI/FFI manual supplement. Psychological Assessment Resources, Odessa, FL Costa PT Jr, McCrae RR (1989) NEO PI/FFI manual supplement. Psychological Assessment Resources, Odessa, FL
10.
go back to reference De Vries J, Michielsen HJ, Van Heck GL, Drent M (2004) Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS). Br J Health Psychol 9:279–291PubMedCrossRef De Vries J, Michielsen HJ, Van Heck GL, Drent M (2004) Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS). Br J Health Psychol 9:279–291PubMedCrossRef
11.
go back to reference Digman JM (1990) Personality structure: emergence of the five-factor model. Annu Rev Psychol 41:417–440 Digman JM (1990) Personality structure: emergence of the five-factor model. Annu Rev Psychol 41:417–440
12.
go back to reference Goldberg LR (1990) An alternative ‘description of personality’: the big-five factor structure. J Pers Soc Psychol 59:1216–1229PubMedCrossRef Goldberg LR (1990) An alternative ‘description of personality’: the big-five factor structure. J Pers Soc Psychol 59:1216–1229PubMedCrossRef
13.
go back to reference Greenberg DB, Sawicka J, Eisenthal S, Ross D (1992) Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7:38–45PubMedCrossRef Greenberg DB, Sawicka J, Eisenthal S, Ross D (1992) Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7:38–45PubMedCrossRef
14.
go back to reference Headey B, Wearing A (1989) Personality, life events, and subjective well-being: toward a dynamic equilibrium model. J Pers Soc Psychol 57:731–739CrossRef Headey B, Wearing A (1989) Personality, life events, and subjective well-being: toward a dynamic equilibrium model. J Pers Soc Psychol 57:731–739CrossRef
15.
go back to reference Hoekstra HA, Ormel J, De Fruyt F (1996) Handleiding bij de NEO PersoonlijkheidsVragenlijsten NEO-PI-R en NEO-FFI [Manual for the NEO Personality Inventories NEO-PI-R and NEO-FFI]. Swets & Zeitlinger, Lisse, The Netherlands Hoekstra HA, Ormel J, De Fruyt F (1996) Handleiding bij de NEO PersoonlijkheidsVragenlijsten NEO-PI-R en NEO-FFI [Manual for the NEO Personality Inventories NEO-PI-R and NEO-FFI]. Swets & Zeitlinger, Lisse, The Netherlands
16.
go back to reference Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242PubMedCrossRef Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242PubMedCrossRef
17.
go back to reference Jylha P, Isometsa E (2006) The relationship of neuroticism and extraversion to symptoms of anxiety and depression in the general population. Depress Anxiety 23:281–289PubMedCrossRef Jylha P, Isometsa E (2006) The relationship of neuroticism and extraversion to symptoms of anxiety and depression in the general population. Depress Anxiety 23:281–289PubMedCrossRef
18.
go back to reference Lampic C, Thurfjell E, Bergh J, Sjödén P-O (2001) Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 37:463–469PubMedCrossRef Lampic C, Thurfjell E, Bergh J, Sjödén P-O (2001) Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 37:463–469PubMedCrossRef
19.
go back to reference Michielsen HJ, De Vries J, Van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale (FAS). J Psychosom Res 54:345–352PubMedCrossRef Michielsen HJ, De Vries J, Van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale (FAS). J Psychosom Res 54:345–352PubMedCrossRef
20.
go back to reference Michielsen HJ, De Vries J, Van Heck GL, Van de Vijver AJR, Sijtsma K (2004) Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS). Eur J Psychol Assess 20:39–48CrossRef Michielsen HJ, De Vries J, Van Heck GL, Van de Vijver AJR, Sijtsma K (2004) Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS). Eur J Psychol Assess 20:39–48CrossRef
21.
go back to reference Michielsen HJ, De Vries J, Drent M, Peros-Golubicic T (2005) Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diff Lung Dis 22:133–138 Michielsen HJ, De Vries J, Drent M, Peros-Golubicic T (2005) Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diff Lung Dis 22:133–138
22.
go back to reference Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
23.
go back to reference Schroevers MJ, Sanderman R, Van Sonderen E, Ranchor AV (2000) The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 9:1015–1029PubMedCrossRef Schroevers MJ, Sanderman R, Van Sonderen E, Ranchor AV (2000) The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 9:1015–1029PubMedCrossRef
24.
go back to reference Servaes P, Prins J, Verhagen S, Bleijenberg G (2002) Fatigue after breast cancer and in chronic fatigue syndrome. Similarities and differences. J Psychosom Res 52:453–459PubMedCrossRef Servaes P, Prins J, Verhagen S, Bleijenberg G (2002) Fatigue after breast cancer and in chronic fatigue syndrome. Similarities and differences. J Psychosom Res 52:453–459PubMedCrossRef
25.
go back to reference Smets EM, Visser MR, Willems-Groot AF, Garssen B, Oldenburger F, van Tienhoven G, De Haes JC (1998) Fatigue and radiotherapy: (a) experience in patients undergoing treatment. Br J Cancer 78:899–906PubMed Smets EM, Visser MR, Willems-Groot AF, Garssen B, Oldenburger F, van Tienhoven G, De Haes JC (1998) Fatigue and radiotherapy: (a) experience in patients undergoing treatment. Br J Cancer 78:899–906PubMed
26.
go back to reference Smets EMA, Visser MRM, Garssen B, Frijda NH, Oosterveld P, De Haes JCJM (1998) Understanding the level of fatigue in cancer patients undergoing radiotherapy. J Psychosom Res 45:277–293PubMedCrossRef Smets EMA, Visser MRM, Garssen B, Frijda NH, Oosterveld P, De Haes JCJM (1998) Understanding the level of fatigue in cancer patients undergoing radiotherapy. J Psychosom Res 45:277–293PubMedCrossRef
27.
go back to reference Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, Oosterveld P, Smets EM (1999) Revealing response shift in longitudinal research on fatigue—the use of the then test approach. Acta Oncol 38:709–718PubMedCrossRef Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, Oosterveld P, Smets EM (1999) Revealing response shift in longitudinal research on fatigue—the use of the then test approach. Acta Oncol 38:709–718PubMedCrossRef
28.
go back to reference Stone P, Hardy J, Huddart R, A’Hern R, Richards M (2000) Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36:1134–1141PubMedCrossRef Stone P, Hardy J, Huddart R, A’Hern R, Richards M (2000) Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36:1134–1141PubMedCrossRef
29.
go back to reference Stone P, Richards M, A’Hern R, Hardy J (2001) Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22:1007–1015PubMedCrossRef Stone P, Richards M, A’Hern R, Hardy J (2001) Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22:1007–1015PubMedCrossRef
30.
go back to reference Sugawara Y, Akechi T, Okuyama T, Matsuoka Y, Nakano T, Inagaki M, Imoto S, Fujimori M, Hosaka T, Uchitomi Y (2005) Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer 13:628–636PubMedCrossRef Sugawara Y, Akechi T, Okuyama T, Matsuoka Y, Nakano T, Inagaki M, Imoto S, Fujimori M, Hosaka T, Uchitomi Y (2005) Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer 13:628–636PubMedCrossRef
31.
go back to reference Winningham ML (2001) Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer 92:988–997PubMedCrossRef Winningham ML (2001) Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer 92:988–997PubMedCrossRef
32.
go back to reference Young KE, White CA (2006) The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60:29–38PubMedCrossRef Young KE, White CA (2006) The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60:29–38PubMedCrossRef
Metadata
Title
Personality and fatigue in patients with benign or malignant breast disease
Authors
Helen J. Michielsen
Alida F. W. Van der Steeg
Jan A. Roukema
Jolanda De Vries
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0222-2

Other articles of this Issue 9/2007

Supportive Care in Cancer 9/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine